Correlation Between Arcellx and Silverback Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcellx and Silverback Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Silverback Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Silverback Therapeutics, you can compare the effects of market volatilities on Arcellx and Silverback Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Silverback Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Silverback Therapeutics.

Diversification Opportunities for Arcellx and Silverback Therapeutics

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Arcellx and Silverback is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Silverback Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silverback Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Silverback Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silverback Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and Silverback Therapeutics go up and down completely randomly.

Pair Corralation between Arcellx and Silverback Therapeutics

Given the investment horizon of 90 days Arcellx is expected to generate 4.99 times less return on investment than Silverback Therapeutics. But when comparing it to its historical volatility, Arcellx is 1.28 times less risky than Silverback Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Silverback Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  630.00  in Silverback Therapeutics on November 3, 2024 and sell it today you would earn a total of  672.00  from holding Silverback Therapeutics or generate 106.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Arcellx  vs.  Silverback Therapeutics

 Performance 
       Timeline  
Arcellx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Silverback Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silverback Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Arcellx and Silverback Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcellx and Silverback Therapeutics

The main advantage of trading using opposite Arcellx and Silverback Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Silverback Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silverback Therapeutics will offset losses from the drop in Silverback Therapeutics' long position.
The idea behind Arcellx and Silverback Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.